Scientific Director
Bristol-Myers Squibb Company
Jonathan Haulenbeek received his PhD in Analytical Chemistry from Drexel University. He has 20 years experience in the Biopharma industry, including small and large molecule CMC, regulated bioanalysis, protein chemistry and biomarker assay development. He currently leads a team in translational sciences and diagnostics that develops protein reagents and prototype assays in support of biomarker and diagnostic assays. His team also utilizes novel automation workflows that enable high throughput sample analysis and increased assay robustness for various bioanalytical assay formats.